Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis  A. Hedberg,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J. Gonçalves-Pereira, A. Martins, P. Póvoa 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Migrant health—a cause for concern?
The use of dried cerebrospinal fluid filter paper spots as a substrate for PCR diagnosis of the aetiology of bacterial meningitis in the Lao PDR  I. Elliott,
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Public health significance of invasive mosquitoes in Europe
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
J. Gonçalves-Pereira, A. Martins, P. Póvoa 
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain  J.-M. Aguado, C. Lumbreras, D.
Vector control: a cornerstone in the malaria elimination campaign
Do we need new antibiotics?
Oral versus intravenous therapy in the treatment of systemic mycosis
Training for the infectious diseases speciality in Norway
Community-acquired pneumonia: the evolving challenge
The use and therapeutic drug monitoring of teicoplanin in the UK
Laboratory diagnosis and biosafety issues of biological warfare agents
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar 
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus.
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
W.A. Craig  Clinical Microbiology and Infection 
Voriconazole concentrations and outcome of invasive fungal infections
Pathogenesis of catheter-related infections: lessons for new designs
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Abstracts cont. Clinical Microbiology and Infection
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Reducing antibiotic use in influenza: challenges and rewards
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Repeat lumbar puncture in adults with bacterial meningitis
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Clinical infection services—the Leiden experience
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain  O. Dumitrescu,
Statin use and clinical outcomes among pneumonia patients
Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin  G. Drusano  Clinical Microbiology and Infection 
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
Microarray-based characterisation of a Panton–Valentine leukocidin-positive community- acquired strain of methicillin-resistant Staphylococcus aureus 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis  A. Hedberg, H-G. Hårdemark, B. Olsson-Liljequist, J. Sjölin  Clinical Microbiology and Infection  Volume 10, Issue 8, Pages 765-768 (August 2004) DOI: 10.1111/j.1469-0691.2004.00953.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Cerebrospinal fluid (CSF) concentration-time curve of rifampicin on day 2 and day 4 after initiation of intravenous treatment with rifampicin 900 mg once-daily (body weight 85 kg). The CSF volumes produced were 150 mL/24 h and 105 mL/24 h, respectively. The serum (S) curve represents the mean of the values obtained on day 2 and day 4. There were no significant differences in the serum concentrations between day 2 and day 4. Clinical Microbiology and Infection 2004 10, 765-768DOI: (10.1111/j.1469-0691.2004.00953.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Cerebrospinal fluid (CSF) concentration-time curve of fusidic acid on day 2 and day 4 after initiation of intravenous treatment with fusidic acid 500 mg three-times-daily (body weight 85 kg). The CSF volumes produced were 150 mL/24 h and 105 mL/24 h, respectively. The serum (S) curve represents the mean of the values obtained on day 2 and day 4. On day 4, the serum concentrations were slightly higher than those on day 2, with a mean difference of 1.2 mg/L. Clinical Microbiology and Infection 2004 10, 765-768DOI: (10.1111/j.1469-0691.2004.00953.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions